 |
|
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
|
^ Top
F
Future Drivers: Sales Forecast to 2005 static version printer friendly
Future of VLA-4 Antagonist Drugs and Implications for the Regulatory P... static version printer friendly
Future Pharmaceutical Industry Trends: Long-term Opportunities Tempere... static version printer friendly pdf version
^ Top
G
G Protein-coupled Receptors: Molecular Pharmacology static version printer friendly pdf version
Gabapentin - Pipeline Developer static version printer friendly pdf version
Gabapentin - Pipeline Selector static version printer friendly pdf version
Gadopentetic acid - Pipeline Developer static version printer friendly pdf version
Gadopentetic acid - Pipeline Selector static version printer friendly pdf version
Gaining Competitive Advantage in Pharmaceutical Markets static version printer friendly
Galantamine - Pipeline Developer static version printer friendly pdf version
Galantamine - Pipeline Selector static version printer friendly pdf version
Gastric and Duodenal Ulcer Therapy Area Pipeline Report static version printer friendly pdf version
Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Fo... static version printer friendly pdf version
Gastroesophageal Reflux Disease Therapy Area Pipeline Report static version printer friendly pdf version
Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report static version printer friendly pdf version
Gastrointestinal Disorders Therapy Area Pipeline Report static version printer friendly pdf version
Gaucher's Disease Therapy Area Pipeline Report static version printer friendly pdf version
Gefitinib - Pipeline Developer static version printer friendly pdf version
Gefitinib - Pipeline Selector static version printer friendly pdf version
Gemcitabine - Pipeline Developer static version printer friendly pdf version
Gemcitabine - Pipeline Selector static version printer friendly pdf version
Gene Expression Reagent Market Revenue, 2005 static version printer friendly pdf version
Gene Expression Reagents Markets static version printer friendly pdf version
Gene Silencing With RNA Interference: A New Generation of Pharmaceutic... static version printer friendly
Gene Therapy: Current Status and Prospects static version printer friendly
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories: U.S.... static version printer friendly pdf version
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories: U.S.... static version printer friendly pdf version
Generic Drug Applications and Approvals in the U.S., 1995-2006 static version printer friendly pdf version
Generic Series: Optimizing Brand Lifecycle Management Winning Strategi... static version printer friendly pdf version
GenericHandbook - A Guide to the Generic Drug Industry in the US - 3rd... static version printer friendly pdf version
Generics Growth Strategies: Cost Containment and M&A Shape the Global ... static version printer friendly pdf version
Generics in Japan static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes - Gauchers Disease Drug Pipe... static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes - Turners Syndrome Drug Pipe... static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes Gauchers Disease static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes Turners Syndrome static version printer friendly pdf version
Genetic Effects on Environmental Vulnerability to Disease static version printer friendly pdf version
Genetic Technology News (Technical Insights) static version printer friendly pdf version
German Clinical Chemistry And Immunodiagnostics Markets static version printer friendly pdf version
German Drug Sector: Sector Report static version printer friendly pdf version
German Pharma Sector Analysis static version printer friendly pdf version
German Pharmaceutical Industry: Sector Report static version printer friendly pdf version
German Pharmaceutical Sector: Sector Report static version printer friendly pdf version
Germany Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Germany Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Getting Maximum Benefit from Combination Products static version printer friendly pdf version
Ghrelin: Pharmaceutical and Therapeutic Opportunities for the Treatmen... static version printer friendly
Gilead: PharmaVitae Profile static version printer friendly pdf version
Gingivitis and Periodontitis Therapy Area Pipeline Report static version printer friendly pdf version
Glatiramer acetate - Pipeline Developer static version printer friendly pdf version
Glatiramer acetate - Pipeline Selector static version printer friendly pdf version
Glaucoma Pharmaceuticals - Global Strategic Business Report static version printer friendly pdf version
Glaucoma Therapy Area Pipeline Report static version printer friendly pdf version
GlaxoSmithKline: Performance, Capabilities, Goals and Strategies in th... static version printer friendly pdf version
Glimepiride - Pipeline Developer static version printer friendly pdf version
Glimepiride - Pipeline Selector static version printer friendly pdf version
Glioblastoma - Is There life After Temodar? static version printer friendly
Glioblastoma Review - Temodar partnering pipeline drugs static version printer friendly pdf version
Global Active Pharmaceutical Ingredients Market: An Outlook static version printer friendly pdf version
Global Alzheimer Drugs Market: An Analysis static version printer friendly pdf version
Global Animal Health Market: Emerging Markets Driving Growth static version printer friendly pdf version
Global Anti Counterfeit Packaging Technologies Market For Food and Pha... static version printer friendly pdf version
Global Bio-Pharma CMO Market Report static version printer friendly pdf version
Global Biomaterial Market (2009-2014) static version printer friendly pdf version
Global Bulk Drugs Industry Report static version printer friendly pdf version
Global Cardiac Rhythm Management (CRM) Market Report: 2009 Edition static version printer friendly pdf version
Global Chiral Technology Markets static version printer friendly pdf version
Global Clinical Chemistry and Immunodiagnostics Markets Facilities, Te... static version printer friendly pdf version
Global Coronary Stent Market Report static version printer friendly pdf version
Global CRO Spending Trends static version printer friendly pdf version
Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-... static version printer friendly pdf version
Global Dialysis Market Report: 2009 Edition static version printer friendly pdf version
Global Dialysis Market Report: 2010 Edition static version printer friendly pdf version
Global Drug Infusion Pumps Market 2008-2012 static version printer friendly pdf version
Global Drug Manufacturing Industry Outlook to 2010: Buyer Spend and Pr... static version printer friendly pdf version
Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sale... static version printer friendly pdf version
Global Drug Sales Market Share, 2002 vs. 2006 static version printer friendly
Global Drug Sales, 2002 vs. 2003 static version printer friendly
Global Femtocell Equipment Market static version printer friendly pdf version
Global HIV Market: An Analysis static version printer friendly pdf version
Global Home Healthcare Market (2009-2014) static version printer friendly pdf version
Global Industry Monitor 35 Industries - Feb 07 static version printer friendly pdf version
Global Intravenous (IV) Iron Drugs Market: Potential Opportunities static version printer friendly pdf version
Global Life Science Intermediates Market Dynamics and Trends static version printer friendly pdf version
Global Market for Catalyst Regeneration by Site Technology, 2002-2005 static version printer friendly pdf version
Global Market for Molecular Diagnostic Testing, 2000-2008 static version printer friendly
Global Market for Nucleic Acid Testing, 2000-2008 static version printer friendly
Global Market: Biopharmaceuticals Market Trends & Competition static version printer friendly pdf version
Global Markets for Hyaluronic Acid Viscosupplementation 2009-2013 static version printer friendly pdf version
Global Markets for Lancets static version printer friendly pdf version
Global Markets for Nuclear Medicine Systems 2009-2013 static version printer friendly pdf version
Global Medical Devices Industry Outlook to 2010: Marketing and Sales S... static version printer friendly pdf version
Global Ophthalmic Market: Focus on Glaucoma static version printer friendly pdf version
Global Oral Antibiotic Market, 2004-2010 static version printer friendly pdf version
Global Pharma Industry Monitor (January-March, 2008) static version printer friendly pdf version
Global Pharma Industry Monitor (October-December, 2007) static version printer friendly pdf version
Global Pharmaceutical Contract Manufacturing Markets static version printer friendly pdf version
Global Pharmaceutical IT Spending Forecast through 2013 (Market Model)... static version printer friendly pdf version
Global Pharmaceutical Launches: Marketing Budgets and Staffing (Phase ... static version printer friendly
Global Pharmaceutical Market Dynamics and Trends Through 2016 static version printer friendly pdf version
Global Pharmaceutical Market Forecast to 2012 static version printer friendly pdf version
Global Pharmaceutical Product Lifecycle Management Forecast 2006-2012 ... static version printer friendly pdf version
Global Pharmaceutical Sales, 2004-2012 static version printer friendly pdf version
Global Pharmaceuticals static version printer friendly
Global Pharmaceuticals & Biotechnology static version printer friendly
Global Pharmaceuticals - Yearly Update 2006 static version printer friendly
Global Pharmaceuticals and Biotechnology static version printer friendly pdf version
Global Pharmaceuticals and Medicine Manufacturing static version printer friendly pdf version
Global Pharmaceuticals Industry 2006 - Power Point Presentation (Edita... static version printer friendly
Global Pharmaceuticals, Biotechnology & Life Sciences static version printer friendly
Global Pipeline Review & Analysis of Hematological Malignancies static version printer friendly pdf version
Global Radiation Therapy Equipment Market: Opportunities on the Rise static version printer friendly pdf version
Global Sales of Abbott’s Kaletra, 2000-2006 static version printer friendly pdf version
Global Spine Market Report: 2009 Edition static version printer friendly pdf version
Global Top 10 Pharmaceutical Companies - Industry, Financial and SWOT ... static version printer friendly pdf version
Global Vaccine Market Forecast to 2012 static version printer friendly pdf version
Global Vaccines Market static version printer friendly pdf version
Glossary of Phytochemicals static version printer friendly pdf version
Glucose Monitoring static version printer friendly
Glucose Monitoring Devices Market Worldwide (2010 – 2014) static version printer friendly pdf version
Glutathione and Sulfur Amino Acids in Human Health and Disease static version printer friendly pdf version
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery ... static version printer friendly pdf version
GMP for Botanicals static version printer friendly pdf version
GMP Review static version printer friendly pdf version
Gout Therapy Area Pipeline Report static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Green Chemistry: How will it affect the future of the chemical industr... static version printer friendly pdf version
Growth Hormone Deficiency Therapy Area Pipeline Report static version printer friendly pdf version
Growth Opportunities for Left Ventricular Assist Devices (LVAD) in Hea... static version printer friendly pdf version
Guide to Good Facility Design, 2nd Edition static version printer friendly pdf version
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceu... static version printer friendly pdf version
Guide to Valuation of Pharmaceutical Licensing Deals static version printer friendly pdf version
Guidebook for Drug Regulatory Submissions static version printer friendly pdf version
^ Top
H
H1N1 Vaccines - Global Strategic Business Report static version printer friendly pdf version
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Repo... static version printer friendly pdf version
Handbook of Pharmaceutical Additives-Third Ed. static version printer friendly pdf version
Handbook of Systemic Drug Treatment in Dermatology static version printer friendly pdf version
Handbook of Therapeutic Antibodies: Technologies, Emerging Development... static version printer friendly pdf version
Handheld Applications: Reaching Physicians At the Point of Care static version printer friendly pdf version
HCV R&D and Business Development Database static version printer friendly
HDV-Insulin (HDV-I) - R & D Biopharmaceutical & Pharmaceutical Product... static version printer friendly pdf version
Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to ... static version printer friendly pdf version
Head and Neck Cancer Therapy Area Pipeline Report static version printer friendly pdf version
Head lice Therapy Area Pipeline Report static version printer friendly pdf version
Healing Fibromyalgia: The Three-Step Solution static version printer friendly pdf version
Health and Wellness - Nutritionals - China static version printer friendly pdf version
Health and Wellness - Nutritionals - Ecuador static version printer friendly pdf version
Health and Wellness - Nutritionals in Denmark static version printer friendly pdf version
Health and Wellness - Nutritionals in Romania static version printer friendly pdf version
Health and Wellness - Nutritionals in the US static version printer friendly pdf version
Health and Wellness Health Products - Germany static version printer friendly pdf version
Health Coach Hiring, Training and ROI: Profiting from Behavior Change static version printer friendly pdf version
Health Economics and Financing, 4th Edition static version printer friendly pdf version
Healthcare Review: Cancer - October 2002 static version printer friendly
Healthcare Review: Cancer - September 2002 static version printer friendly
Healthcare Review: Cardiovascular - October 2002 static version printer friendly
Healthcare Review: Cardiovascular - September 2002 static version printer friendly
Healthcare Review: CNS - October 2002 static version printer friendly
Healthcare Review: CNS - September 2002 static version printer friendly
Healthcare Review: eHealth - October 2002 static version printer friendly
Healthcare Review: eHealth - September 2002 static version printer friendly
Healthcare Review: Immune Disorders and Inflammation - October 2002 static version printer friendly
Healthcare Review: Infectious Diseases - September 2002 static version printer friendly
Healthcare Review: Licensing - September 2002 static version printer friendly
Healthcare: Global Industry Overview static version printer friendly pdf version
Hearing Aid Market Report: 2010 Edition static version printer friendly pdf version
Heart Disease Death Rate by Race and Sex in the U.S., 1979-2006 static version printer friendly pdf version
Helicobacter Pylori Infections Therapy Area Pipeline Report static version printer friendly pdf version
Helminthic Infestations Therapy Area Pipeline Report static version printer friendly pdf version
Hemodynamic Rounds: Interpretation of Cardiac Pathophysiology from Pre... static version printer friendly pdf version
Hemophilia - Pipeline Assessment and Market Forecasts to 2017 static version printer friendly pdf version
Hemorrhage Therapy Area Pipeline Report static version printer friendly pdf version
Hemorrhoids Therapy Area Pipeline Report static version printer friendly pdf version
Heparin: US, Europe, Japan Test Volume Forecasts by Country and Market... static version printer friendly pdf version
Hepatitis B Therapy Area Pipeline Report static version printer friendly pdf version
Hepatitis B Vaccine - Pipeline Developer static version printer friendly pdf version
Hepatitis B Vaccine - Pipeline Selector static version printer friendly pdf version
Hepatitis C Therapeutics Market – Taiwan static version printer friendly pdf version
Hepatitis C Therapeutics Market—Thailand static version printer friendly pdf version
Hepatitis C Therapy Area Pipeline Report static version printer friendly pdf version
Hepatitis C Virus And Therapeutics - A Global Update of Market Trends ... static version printer friendly pdf version
Hepatitis in China - Liver Let Die? static version printer friendly
Hepatitis Therapy Area Pipeline Report static version printer friendly pdf version
Herbal Drugs Industry static version printer friendly pdf version
Herceptin Worldwide Sales, 1999-2006 static version printer friendly pdf version
Herg: Technology and Market Analysis static version printer friendly
Herpes And Respiratory Antivirals - Leaders Rise And Fall static version printer friendly
Herpes Simplex - Pipeline Assessment and Market Forecasts to 2017 static version printer friendly pdf version
Herpes Simplex Virus Infection Therapy Area Pipeline Report static version printer friendly pdf version
Herpes zoster infections Therapy Area Pipeline Report static version printer friendly pdf version
High Content Screening (HCS): An Industry Analysis static version printer friendly
Highlights of the 18th Uicc International Cancer Congress - From Front... static version printer friendly
HIPAA and Human Subject Research: A Question and Answer Reference Guid... static version printer friendly
Hirudin - Pipeline Selector static version printer friendly pdf version
Histological Analysis of Endocrine Disruptive Effects in Small Laborat... static version printer friendly pdf version
Histone Deacetylase inhibitors static version printer friendly
Hit and Lead Profiling: Identification and Optimization of Drug-like M... static version printer friendly pdf version
HIV Drugs - Global Strategic Business Report static version printer friendly pdf version
HIV Therapies in the EU: Gauging the Potential of Atripla: A Survey of... static version printer friendly pdf version
HIV Vaccine Update: R&D Innovation Critical in the Wake of Recent Setb... static version printer friendly pdf version
Hodgkin Lymphoma Therapy Area Pipeline Report static version printer friendly pdf version
Hong Kong Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Hong Kong Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Hormonal Contraception Market, 2003-2011 static version printer friendly pdf version
Hormonal Contraceptives Market Forecast static version printer friendly pdf version
Hormone Replacement Therapy Therapy Area Pipeline Report static version printer friendly pdf version
Hospital Antibiotics Pipeline Analysis: Big Pharma's Retreat Creates O... static version printer friendly
How Adopting Diabetes Protocols and Monitoring Programs Can Strengthen... static version printer friendly pdf version
How Drugs Are Developed: 3rd Edition static version printer friendly pdf version
How Electronic Data Capture Will Change Healthcare and Pharmaceutical ... static version printer friendly
How to Get Ahead with Pharmacogenomics static version printer friendly pdf version
How to Integrate Personalized Medicine into Business Strategies static version printer friendly pdf version
How to License Pharmaceutical Assets static version printer friendly pdf version
How to React to Parallel Trade static version printer friendly pdf version
How Will Recent Safety Concerns Affect PPAR-Gamma Agonists? static version printer friendly pdf version
HPLC for Pharmaceutical Scientists static version printer friendly pdf version
HRT: Major Milestones - Current Perspectives on HRT and Menopause static version printer friendly pdf version
Human Embryonic Stem Cells: The Practical Handbook static version printer friendly pdf version
Human Growth Hormone 2001 - State-of-the-Science and Strategic Opportu... static version printer friendly
Human Papillomavirus - Vaccines, Then Antivirals? static version printer friendly
Human Vaccines - Global Market Opportunities static version printer friendly pdf version
Human Vaccines - Global Strategic Business Report static version printer friendly
Hungary Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Hungary Pharmaceuticals & Healthcare Report Q4 2006 static version printer friendly pdf version
Hungary Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Hungary Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Huntington Disease Therapy Area Pipeline Report static version printer friendly pdf version
Huntington’s Disease Drug Development - Hope and Opportunity in an Act... static version printer friendly pdf version
Huntingtons Disease Therapeutics - Global Strategic Business Report static version printer friendly pdf version
Hyaluronic Acid - Pipeline Selector static version printer friendly pdf version
Hybrid Therapy for Atrial Fibrillation - Catheter ablation: Hype or Ho... static version printer friendly pdf version
Hydroxychloroquine - Pipeline Selector static version printer friendly pdf version
Hyper pigmentation Therapy Area Pipeline Report static version printer friendly pdf version
Hypercalcemia Therapy Area Pipeline Report static version printer friendly pdf version
Hypercholesterolemia Therapy Area Pipeline Report static version printer friendly pdf version
Hyperlipemia Therapy Area Pipeline Report static version printer friendly pdf version
Hyperphosphatemia Therapy Area Pipeline Report static version printer friendly pdf version
Hypertension - Multiple Layers of Therapy Cover all Eventualities static version printer friendly pdf version
Hypertension And Diabetic Kidney Disease - Prevalence, Current Treatme... static version printer friendly pdf version
Hypertension and Heart Failure - Evaluation and Management Clincial Gu... static version printer friendly pdf version
Hypertension Drugs Newly Prescribed or Continued in the U.S., 1994-200... static version printer friendly pdf version
Hypertension: Competing Treatments and Market Entry Considerations static version printer friendly pdf version
Hypertension: Treatments and Prescribing Practices - A Global Survey static version printer friendly pdf version
Hyperthyroidism Therapy Area Pipeline Report static version printer friendly pdf version
Hypocalcemia Therapy Area Pipeline Report static version printer friendly pdf version
Hypogonadism Therapy Area Pipeline Report static version printer friendly pdf version
Hypokalemia Therapy Area Pipeline Report static version printer friendly pdf version
Hypotension Therapy Area Pipeline Report static version printer friendly pdf version
Hypothyroidism Therapy Area Pipeline Report static version printer friendly pdf version
Hypoxia and Consequences static version printer friendly pdf version
^ Top
I
Ibandronic Acid - Pipeline Developer static version printer friendly pdf version
Ibandronic Acid - Pipeline Selector static version printer friendly pdf version
Icact 2001: Highlights of Trial Results, Discussions and Commercial Im... static version printer friendly
Identifying Drug-Resistant Bacterial Infections: Opportunity and Activ... static version printer friendly pdf version
Idiopathic Pulmonary Fibrosis - A New Hope static version printer friendly
Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Market Forecas... static version printer friendly pdf version
Imatinib - Pipeline Developer static version printer friendly pdf version
Imatinib - Pipeline Selector static version printer friendly pdf version
Imidacloprid (Vet) - Pipeline Developer static version printer friendly pdf version
Imidacloprid (Vet) - Pipeline Selector static version printer friendly pdf version
Imiquimod - Pipeline Developer static version printer friendly pdf version
Imiquimod - Pipeline Selector static version printer friendly pdf version
Immunology: A Short Course, 6th Edition static version printer friendly pdf version
Immunology: Clinical Case Studies and Disease Pathophysiology static version printer friendly pdf version
Immunotherapy in Allergic Rhinitis - Moving Away from Injections static version printer friendly
Immunotoxicology Strategies for Pharmaceutical Safety Assessment static version printer friendly pdf version
Impact of Bariatric Surgeries on the Obesity Pharmaceutical Market static version printer friendly
Impact of Generics on the Antidepressant Market static version printer friendly pdf version
Impact of Pharmacogenomics on Public Healthcare Policy: Educating Pati... static version printer friendly pdf version
Impact of the PROactive Study on the Treatment of Type 2 Diabetes static version printer friendly pdf version
Improving the Quality Function: Driving Organizational Impact & Effici... static version printer friendly pdf version
Improving the ROI of the Sales Process: Strategic Use of Licensing Par... static version printer friendly
IMS Pharma Pricing & Reimbursement Concise Guide Series Central & East... static version printer friendly pdf version
IMS Pharma Pricing & Reimbursement Concise Guide Series Selected Asia-... static version printer friendly pdf version
IMS Pharma Pricing & Reimbursement Concise Guide Series The Americas static version printer friendly pdf version
IMS Pharmaceutical Pricing and Reimbursement: A Concise Guide 2007 static version printer friendly pdf version
IMS Pharmacoeconomics Report static version printer friendly pdf version
IMS Therapy Report: Asthma & COPD static version printer friendly pdf version
IMS World Review Country Profile - Argentina static version printer friendly pdf version
IMS World Review Country Profile - Australia static version printer friendly pdf version
IMS World Review Country Profile - Austria static version printer friendly pdf version
IMS World Review Country Profile - Belgium static version printer friendly pdf version
IMS World Review Country Profile - Brazil static version printer friendly pdf version
IMS World Review Country Profile - Canada static version printer friendly pdf version
IMS World Review Country Profile - China Hospital static version printer friendly pdf version
IMS World Review Country Profile - Czech Republic static version printer friendly pdf version
IMS World Review Country Profile - Egypt static version printer friendly pdf version
IMS World Review Country Profile - Finland static version printer friendly pdf version
IMS World Review Country Profile - Russian Federation static version printer friendly pdf version
IMS World Review Country Profile - South Africa static version printer friendly pdf version
IMS World Review Country Profile - South Korea static version printer friendly pdf version
IMS World Review Country Profile - Taiwan static version printer friendly pdf version
In Vivo Glucose Sensing static version printer friendly pdf version
IN-105 - R & D Biopharmaceutical & Pharmaceutical Product Profile static version printer friendly pdf version
Incontinence Products in Czech Republic static version printer friendly pdf version
Incontinence Products in the United States static version printer friendly pdf version
IND Submissions: A Primer static version printer friendly pdf version
Indapamide - Pipeline Developer static version printer friendly pdf version
Indapamide - Pipeline Selector static version printer friendly pdf version
India CRO Directory & Industry Tracker static version printer friendly pdf version
India Pharmaceutical Market static version printer friendly pdf version
India Pharmaceutical Regulatory Report 2010 static version printer friendly pdf version
India Pharmaceutical Regulatory Report 2010 + Appendix static version printer friendly pdf version
India Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
India Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
India Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
India Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
India Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
India Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
India: Pharmaceutical static version printer friendly pdf version
India: Pharmaceutical and Biotechnology Opportunities static version printer friendly pdf version
Indian Aesthetic (Cosmetic Surgery) Industry: A Primer static version printer friendly pdf version
Indian Biopharmaceuticals Industry Report static version printer friendly pdf version
Indian Biotechnology Sector: Industry Profile static version printer friendly pdf version
Indian Bulk Drug Industry Insight static version printer friendly pdf version
Indian Chemicals Sector: Industry Profile static version printer friendly pdf version
Indian Contract Research Manufacturing & Services static version printer friendly pdf version
Indian Drug Sector: Industry Profile static version printer friendly pdf version
Indian Drug Sector: Sector Report static version printer friendly pdf version
Indian Healthcare Sector: Industry Profile static version printer friendly pdf version
Indian Pharmaceutical Directory 2010 static version printer friendly pdf version
Indian Pharmaceutical Industry static version printer friendly pdf version
Indian Pharmaceutical Industry static version printer friendly pdf version
Indian Pharmaceutical Industry - Quarterly Updates ( Jan - Mar 2006) static version printer friendly pdf version
Indian Pharmaceutical Industry - SWOT Framework Analysis static version printer friendly pdf version
Indian Pharmaceutical Industry: Issues and Opportunities static version printer friendly
Indian Pharmaceutical Industry: Sector Report static version printer friendly pdf version
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities static version printer friendly pdf version
Indian Pharmaceutical Sector: Industry Profile static version printer friendly pdf version
Indian Pharmaceutical Sector: Sector Report static version printer friendly pdf version
Indian Pharmaceuticals Industry Report static version printer friendly
Indian Vaccines Report static version printer friendly pdf version
Indias Growth Prospects in Pharma: Evolution, Not Revolution static version printer friendly pdf version
Indigestion Preparations in the BRIC (Brazil, Russia, India, China) Co... static version printer friendly pdf version
Indigestion Therapy Area Pipeline Report static version printer friendly pdf version
Indonesia Pharmaceuticals & Healthcare Report Q3 2007 static version printer friendly pdf version
Indonesia Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Industrial Bioprocessing (Technical Insights) static version printer friendly pdf version
Industrial Microbiology Market Review 3rd Edition static version printer friendly pdf version
Industrial Pharmaceutical Microbiology: Standards & Controls static version printer friendly pdf version
Industry Analysis - Changing Dynamics in Worldwide Psychiatric Franchi... static version printer friendly pdf version
Industry Analysis: Where Is the Innovation in Neurology Markets? static version printer friendly pdf version
Industry Insight Clinical Trials in India static version printer friendly pdf version
Industry Snapshot: How Companies Are Using M&As to Strategic Advantage... static version printer friendly pdf version
Industry Spotlight on Drugs static version printer friendly
Industry Spotlight on Retail - Drug Stores and Proprietary Stores static version printer friendly pdf version
Industry Spotlight on Wholesale - Drugs, Chemicals and Allied Products... static version printer friendly pdf version
Infant Mortality Rate by Country, 2008 static version printer friendly pdf version
Infection Rate of Invasive Pneumococcal Disease in the U.S., 1998-2006... static version printer friendly pdf version
Infection Rate of Serotype 19A by Age Group in the U.S., 1998-2006 static version printer friendly pdf version
Infectious Disease Diagnostics Markets in sub-Saharan Africa static version printer friendly pdf version
Infertility Therapy Area Pipeline Report static version printer friendly pdf version
Inflammation Therapy Area Pipeline Report static version printer friendly pdf version
Inflammatory and Autoimmune Disorders of the Nervous System in Childre... static version printer friendly pdf version
Inflammatory Bowel Disease Therapeutics - Global Strategic Business Re... static version printer friendly pdf version
Inflammatory Bowel Disease Therapy Area Pipeline Report static version printer friendly pdf version
Influencing Physician Prescribing: Online Strategies static version printer friendly
Influencing the Development of NICE Technology Appraisals and Guidelin... static version printer friendly pdf version
Influenza Therapy Area Pipeline Report static version printer friendly pdf version
InfoBase Cd-rom Directory of over 17,000 Life Science Companies and Or... static version printer friendly pdf version
Inhalable Drug Delivery: Industry Holds its Breath in Anticipation of ... static version printer friendly pdf version
Injectable Drug Delivery: Market Impact and Industry Trends static version printer friendly pdf version
Injectable Generic Drugs: Prospects & Opportunities to 2013 static version printer friendly pdf version
Innovation Driving Trauma Market static version printer friendly pdf version
Innovations and Trends in Clinical Trials - Microdosing (Phase 0 Trial... static version printer friendly pdf version
Innovations in Cardiovascular Disease Management: Latest Surgical Proc... static version printer friendly pdf version
Innovations in Patient-Focused Initiatives: Case Studies in Reaching, ... static version printer friendly pdf version
Innovative Clinical Trial Design and Management: Trends, Success Stori... static version printer friendly pdf version
Innovative Drug R&D in China static version printer friendly pdf version
Innovative Targeted Therapies - Smart Drugs On Target For Increasing G... static version printer friendly pdf version
Insights into Platform Technology and Early-Stage Pipeline Mergers and... static version printer friendly pdf version
Insomnia - Drug Pipeline Analysis and Market Forecasts to 2015 static version printer friendly pdf version
Insomnia - Sanofi-Synthelabo to Drive Growth of This Potentially Lucra... static version printer friendly pdf version
Insomnia and Sleep Disorders Therapy Area Pipeline Report static version printer friendly pdf version
Insomnia: Wake-Up Call for a Sleepy Market static version printer friendly
Instant Clinical Pharmacology, 2nd Edition static version printer friendly pdf version
Insulin Delivery Devices Market Analysis and Future Forecast static version printer friendly pdf version
Integrating Diagnostics and Therapeutics for Targeted Therapies, Part ... static version printer friendly
Integrating Diagnostics and Therapeutics for Targeted Therapies, Part ... static version printer friendly pdf version
Intellectual Property and Outsourcing in China: Minimizing Risk whilst... static version printer friendly pdf version
IntelliNews Bulgarian Pharmaceutical Report static version printer friendly
IntelliNews Romanian Pharmaceutical Report static version printer friendly
Interferons - State-of-the-Science and Strategic Opportunities static version printer friendly
Intermittent Claudication Therapy Area Pipeline Report static version printer friendly pdf version
International Directory of Pharmaceutical Companies 2010 static version printer friendly pdf version
International IT Regulations and Compliance: Quality Standards in the ... static version printer friendly pdf version
International Tables for Crystallography, 2nd Edition, 8 Volume Set static version printer friendly pdf version
International Tables for Crystallography, Volume A1, 2nd Edition, Symm... static version printer friendly pdf version
International Trends in the Use of Health Technology Assessment static version printer friendly pdf version
Interstitial Cystitis - Few Treatments, Poor Outcome static version printer friendly
Interstitial Cystitis Therapy Area Pipeline Report static version printer friendly pdf version
Intranasal Drug Delivery - US Market Trends & Analysis static version printer friendly pdf version
Intravascular Ultrasound (IVUS) Market: An Analysis static version printer friendly pdf version
Introduction to Meta-Analysis static version printer friendly pdf version
InvestFrost Healthcare - European Insulin Delivery Devices Market Outl... static version printer friendly pdf version
Investigating Clinical Trial Costs: Comparative Analysis of Trial Cost... static version printer friendly pdf version
Investing in Stem Cell Companies in 2010 and Beyond static version printer friendly pdf version
Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Q... static version printer friendly pdf version
Ipsen: PharmaVitae Profile static version printer friendly pdf version
Iran Health Indicators and Health Care System static version printer friendly pdf version
Iran Healthcare and Pharmaceuticals Overview static version printer friendly pdf version
Iran Pharmaceutical Import Market Review, 2004-2008 static version printer friendly pdf version
Iran Pharmaceutical Local Manufacturing Market Review, 2004-2008 static version printer friendly pdf version
Iran Pharmaceutical Market Review, 2004-2008 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Irbesartan - Pipeline Developer static version printer friendly pdf version
Irbesartan - Pipeline Selector static version printer friendly pdf version
Irinotecan - Pipeline Developer static version printer friendly pdf version
Irinotecan - Pipeline Selector static version printer friendly pdf version
Iron Sucrose - Pipeline Developer static version printer friendly pdf version
Iron Sucrose - Pipeline Selector static version printer friendly pdf version
Irritable Bowel Syndrome static version printer friendly pdf version
Irritable Bowel Syndrome Therapy Area Pipeline Report static version printer friendly pdf version
Is There Commercial Opportunity in the Development of a New Influenza ... static version printer friendly
Ischemia Therapy Area Pipeline Report static version printer friendly pdf version
Isotretinoin - Pipeline Developer static version printer friendly pdf version
Isotretinoin - Pipeline Selector static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Issues and Trends in U.S. Outpatient Prescription Drug Reimbursement static version printer friendly pdf version
IT Spending Study At Major Pharma Companies static version printer friendly pdf version
It's All About the Biomarkers: How 2008's Biomarker-Based Partnering I... static version printer friendly pdf version
Italian Clinical Chemistry And Immunodiagnostics Markets static version printer friendly pdf version
Italy Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Itraconazole - Pipeline Developer static version printer friendly pdf version
Itraconazole - Pipeline Selector static version printer friendly pdf version
ITs role in the evolving pharma industry - Addressing the R&D producti... static version printer friendly
iTV in Pharmaceutical Marketing: Building Customer Relationships Throu... static version printer friendly pdf version
IVD Markets in sub-Saharan Africa static version printer friendly pdf version
Ivermectin & Praziquantel (Vet) - Pipeline Selector static version printer friendly pdf version
^ Top
J
Japan - Pharmaceutical Industry Overview static version printer friendly pdf version
Japan Pharma Takes its Place in the Global Market static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Japan: Opening the Door to Global Clinical Trials static version printer friendly pdf version
Japanese Biotechnology Sector: Industry Profile static version printer friendly pdf version
Japanese Chemicals Sector: Industry Profile static version printer friendly pdf version
Japanese Clinical Chemistry And Immunodiagnostics Markets static version printer friendly pdf version
Japanese Drug Sector: Industry Profile static version printer friendly pdf version
Japanese Drug Sector: Sector Report static version printer friendly pdf version
Japanese Healthcare Sector: Industry Profile static version printer friendly pdf version
Japanese Pharmaceutical Industry: Sector Report static version printer friendly pdf version
Japanese Pharmaceutical Sector: Industry Profile static version printer friendly pdf version
Japanese Pharmaceutical Sector: Sector Report static version printer friendly pdf version
Johnson & Johnson: Performance, Capabilities, Goals and Strategies in ... static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Journal of Drug Education static version printer friendly pdf version
Junk Medicine: Doctors, Lies and the Addiction Bureaucracy static version printer friendly pdf version
^ Top
K
Kazakhstan - Pharmaceutical Industry Overview static version printer friendly pdf version
Kazakhstan Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Kenya - Pharmaceutical Industry Overview static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Key Factors in U.S. Pharmaceutical Pricing static version printer friendly pdf version
Key ID market events 2002 static version printer friendly pdf version
Key Opinion Leaders: Relationship Management and Segmentation Data static version printer friendly pdf version
Key Players in Pharmaceutical Contract Manufacturing: Market Developme... static version printer friendly pdf version
Key Sub-Saharan African Infectious Disease Pharmaceutical Markets static version printer friendly pdf version
Key Trends Fueling the Boom in Genetic Testing static version printer friendly pdf version
Key Trends In Drug-diagnostic Co-Development: Identifying Collaborativ... static version printer friendly pdf version
Key Trends in the Asthma and Copd Market - Uncertain times for novel i... static version printer friendly
KeywordPharma Conference Insights - Drug Safety for Marketed Drugs static version printer friendly pdf version
KeywordPharma Conference Insights - European CME Forum: First Annual M... static version printer friendly pdf version
KeywordPharma Conference Insights - Marketing ROI for Pharma static version printer friendly pdf version
KeywordPharma Conference Insights - Patient Compliance Europe static version printer friendly pdf version
KeywordPharma Conference Insights - Pharma Marketing ROI static version printer friendly pdf version
KeywordPharma Conference Insights - Pharma Sales World 2007 - Advanced... static version printer friendly pdf version
KeywordPharma Conference Insights - Strategies and Solutions for Publi... static version printer friendly pdf version
Kick-Starting R&D in India: Challenges and Opportunities static version printer friendly pdf version
Kidney Cancer Therapy Area Pipeline Report static version printer friendly pdf version
Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug ... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Diabetic Nephropathy Drug Pipeline... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Erectile Dysfunction Drug Pipeline... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Hyperphosphatemia Drug Pipeline Re... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Kidney Stones Drug Pipeline Report... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Overactive Bladder Drug Pipeline R... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline... static version printer friendly pdf version
Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia static version printer friendly pdf version
Kidneys and Genito-Urinary System Diabetic Nephropathy static version printer friendly pdf version
Kidneys and Genito-Urinary System Erectile Dysfunction static version printer friendly pdf version
Kidneys and Genito-Urinary System Hyperphosphatemia static version printer friendly pdf version
Kidneys and Genito-Urinary System Kidney Stones static version printer friendly pdf version
Kidneys and Genito-Urinary System Overactive Bladder static version printer friendly pdf version
Kidneys and Genito-Urinary System Urinary Incontinence static version printer friendly pdf version
Kinase Inhibitor Drugs static version printer friendly pdf version
Kinase Screening & Profiling Trends 2008 Market Report static version printer friendly pdf version
Kinases: Advanced Strategies and Multiple Targets for Drug Discovery static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
^ Top
L
Label Free Binding Analysis Trends 2008 Market Report static version printer friendly pdf version
Labor and Delivery Therapy Area Pipeline Report static version printer friendly pdf version
Laboratory Equipment Market Report 2008 static version printer friendly pdf version
Lacidipine static version printer friendly pdf version
Lacidipine - Pipeline Developer static version printer friendly pdf version
Lamivudine - Pipeline Developer static version printer friendly pdf version
Lamivudine - Pipeline Selector static version printer friendly pdf version
Lamotrigine - Pipeline Developer static version printer friendly pdf version
Lamotrigine - Pipeline Selector static version printer friendly pdf version
Lansoprazole - Pipeline Developer static version printer friendly pdf version
Lansoprazole - Pipeline Selector static version printer friendly pdf version
Lapatinib - Pipeline Developer static version printer friendly pdf version
Lapatinib - Pipeline Selector static version printer friendly pdf version
Large Pharma: 2004 A Year Of Progress static version printer friendly
Latanoprost - Pipeline Developer static version printer friendly pdf version
Latanoprost - Pipeline Selector static version printer friendly pdf version
Late Stage Anti-hypertensives R&D Update - Critical Factors for Succes... static version printer friendly pdf version
Latest Chinese Regulations for Imported Drug Registration: A Comprehen... static version printer friendly pdf version
Latin American Markets for Facial Injectables 2010-2014 static version printer friendly pdf version
Latin American Pharmaceutical Market Outlook To 2014: Policy Environme... static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Launching a Medicine or a Product in French Pharmacies static version printer friendly pdf version
Leachables and Extractables - 2009 Conference Proceedings static version printer friendly pdf version
Lead Optimization Strategies: Future Developments, Threats and Opportu... static version printer friendly pdf version
Leading Cardiovascular Players 2002 - Portfolios Requiring Replacement... static version printer friendly pdf version
Leading Life Science Intermediates Companies Collaborations static version printer friendly pdf version
Leading Life Science Intermediates Companies Comparative Analysis static version printer friendly pdf version
Leading Life Science Intermediates Companies Financial Analyses static version printer friendly pdf version
Leading Life Science Intermediates Companies Marketing Tactics static version printer friendly pdf version
Leading Life Science Intermediates Companies Organizations and Managem... static version printer friendly pdf version
Leading Life Science Intermediates Companies Product Portfolio Analyse... static version printer friendly pdf version
Leading Life Science Intermediates Companies R&D Expenditures and Majo... static version printer friendly pdf version
Leading Life Science Intermediates Companies Strategic Directions static version printer friendly pdf version
Leading Life Science Intermediates Companies Technological Know-How static version printer friendly pdf version
Leading Pharmaceutical Companies Business Organizations and Senior Man... static version printer friendly pdf version
Leading Pharmaceutical Companies Collaborative Arrangements static version printer friendly pdf version
Leading Pharmaceutical Companies Comparative Analysis static version printer friendly pdf version
Leading Pharmaceutical Companies Financial Analyses static version printer friendly pdf version
Leading Pharmaceutical Companies Marketing Tactics static version printer friendly pdf version
Leading Pharmaceutical Companies Product Portfolio Analyses static version printer friendly pdf version
Leading Pharmaceutical Companies R&D Expenditures and Major Programs static version printer friendly pdf version
Leading Pharmaceutical Companies Strategic Directions static version printer friendly pdf version
Leading Pharmaceutical Companies Technological Know-How static version printer friendly pdf version
Lebanon Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Leflunomide - Pipeline Developer static version printer friendly pdf version
Leflunomide - Pipeline Selector static version printer friendly pdf version
Legal and Regulatory Issues in eHealth Security: An Overview of Europe... static version printer friendly
Legal Aspects of Outsourcing in the Pharmaceutical Industry: A Practic... static version printer friendly
Legislation and Industry Status of Human Organ Transplantation static version printer friendly pdf version
Lercanidipine - Pipeline Developer static version printer friendly pdf version
Lercanidipine - Pipeline Selector static version printer friendly pdf version
Letrozole - Pipeline Developer static version printer friendly pdf version
Letrozole - Pipeline Selector static version printer friendly pdf version
Leukemia and Types of Leukemia Therapy Area Pipeline Report static version printer friendly pdf version
Leungs Encyclopedia of Common Natural Ingredients: Used in Food, Drugs... static version printer friendly pdf version
Levetiracetam - Pipeline Developer static version printer friendly pdf version
Levetiracetam - Pipeline Selector static version printer friendly pdf version
Levocetirizine - Pipeline Developer static version printer friendly pdf version
Levocetirizine - Pipeline Selector static version printer friendly pdf version
Levofloxacin - Pipeline Developer static version printer friendly pdf version
Levofloxacin - Pipeline Selector static version printer friendly pdf version
Levosalbutamol - Pipeline Selector static version printer friendly pdf version
Levothyroxine sodium - Pipeline Selector static version printer friendly pdf version
Licensing Strategies - Examining Today’s Pharmaceutical Licensing Tren... static version printer friendly pdf version
Licensing Strategies for Accessing Biomarker Technologies static version printer friendly pdf version
Licensing Strategies: Trends In The Top 20 Pharmaceutical Companies Ac... static version printer friendly pdf version
Life Expectancy Rate by Country, 2008 static version printer friendly pdf version
Life Science Analytics’ Report Center static version printer friendly pdf version
Life Sciences Industry: Quarterly Deal Review - Second Quarter 2005 static version printer friendly pdf version
Life Sciences Industry: Quarterly Deal Review -Third Quarter 2005 static version printer friendly pdf version
Life Sciences Industry: Quarterly Deal Review--First Quarter 2005 static version printer friendly
Life Sciences Industry: Quarterly Deal Review--Fourth Quarter 2004 static version printer friendly
Lifecycle Management Strategies: Maximizing ROI through Indication Exp... static version printer friendly
Ligand-Binding Assays: Development, Validation, and Implementation in ... static version printer friendly pdf version
Linagliptin (Ondero®, BI 1356) - R & D Biopharmaceutical & Pharmaceuti... static version printer friendly pdf version
Linezolid - Pipeline Developer static version printer friendly pdf version
Linezolid - Pipeline Selector static version printer friendly pdf version
Lipid Regulators - Global Strategic Business Report static version printer friendly pdf version
Lithuania Pharmaceuticals & Healthcare Report Q4 2006 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 static version printer friendly pdf version
Liver Cancer Therapy Area Pipeline Report static version printer friendly pdf version
Liver Diseases (General) Therapy Area Pipeline Report static version printer friendly pdf version
Longs Drug Stores Corp. - Company Analysis static version printer friendly pdf version
Lonza: Performance, Capabilities, Goals and Strategies in the Worldwid... static version printer friendly pdf version
Looking at Chiral Technologies static version printer friendly pdf version
Looking at Offshoring in the Pharmaceutical Industry static version printer friendly pdf version
Loratadine - Pipeline Selector static version printer friendly pdf version
Losartan - Pipeline Developer static version printer friendly pdf version
Losartan - Pipeline Selector static version printer friendly pdf version
Lou Gehrigs Disease - Global Strategic Business Report static version printer friendly pdf version
Lower Detection Limits of HBV DNA Assays static version printer friendly
Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Repor... static version printer friendly pdf version
Lung Cancer Rates in the U.S., 1975-2005 static version printer friendly pdf version
LY2189265 - R & D Biopharmaceutical & Pharmaceutical Product Profile static version printer friendly pdf version
Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016 static version printer friendly pdf version
Lymphoma Therapy Area Pipeline Report static version printer friendly pdf version
^ Top
M
M&A Trends in Pharma static version printer friendly pdf version
M2 Pharma Premium static version printer friendly pdf version
Macular Degeneration Therapy Area Pipeline Report static version printer friendly pdf version
Macular Oedema - Drug Pipeline Analysis and Market Forecasts to 2016 static version printer friendly pdf version
Magnetism in Medicine: A Handbook, 2nd, Completely Revised and Extende... static version printer friendly pdf version
Mail-Order Pharmacies Business Intelligence Report static version printer friendly pdf version
Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need? static version printer friendly pdf version
Malaria Therapy Area Pipeline Report static version printer friendly pdf version
Malaysia - Pharmaceutical Industry Overview static version printer friendly pdf version
Malaysia Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Mammalian Cell Culture: Production Technologies and Market Overview static version printer friendly
Managed Care Pull - Through Excellence: From Formulary Access to Incre... static version printer friendly pdf version
Managed Cares Impact on the U.S. Pharmaceutical Market static version printer friendly pdf version
Managed Markets Account Management: Assessing the Performance of Accou... static version printer friendly pdf version
Managed Markets Market Research: Effective Structures & Activities for... static version printer friendly pdf version
Management Briefing: New Medicare 2009 Outpatient Prospective Payment ... static version printer friendly pdf version
Managing Cross-Functional Teams for Pharmaceutical Product Commerciali... static version printer friendly pdf version
Managing the Competition: Turning Competitive Intelligence into Strate... static version printer friendly pdf version
Managing Toxicology for the Future: Improving Predictive Power Through... static version printer friendly pdf version
Mania Therapy Area Pipeline Report static version printer friendly pdf version
Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics... static version printer friendly pdf version
Mapping the Healthcare Landscape: Bringing Pharmaceuticals into Focus static version printer friendly pdf version
Market Access, Pricing, and Reimbursement News in the Fourth Quarter o... static version printer friendly pdf version
Market Analysis of China Oral Diabetes Medicine --- with a Brief Analy... static version printer friendly pdf version
Market Analysis of Chinas Oral Diabetes Medicine --- With a Brief Anal... static version printer friendly
Market Dynamics: Anti-dyslipidemics - Third Generation Statins Superfl... static version printer friendly
Market Dynamics: Antipsychotics - A Market Driven by Reformulation static version printer friendly
Market Dynamics: Orthopaedic Shoulder and Small Joint Implants - Big P... static version printer friendly
Market for Tissue Implant Applications static version printer friendly pdf version
Market Opportunities and Challenges for Antibody Arrays and Beads: A M... static version printer friendly
Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target S... static version printer friendly pdf version
Market Potential for Hospital Services, Pharmaceuticals and Medical De... static version printer friendly pdf version
Market Report of Medicines for Hypertension Prevention and Cure static version printer friendly pdf version
Market Report on China’s Biopharmaceutical Industry, 2008-2010 static version printer friendly pdf version
Market Research Report of China's Health Food Industry static version printer friendly pdf version
Marketing Drugs in an Era of Pharmacovigilance - Best practice after d... static version printer friendly pdf version
Marketing Mid-Tier Pharmaceutical Brands: Winning Resources for Near-B... static version printer friendly
Marketing Pharmaceuticals to Eastern European Americans static version printer friendly
Mastering Phase IV Clinical Trials static version printer friendly pdf version
Material and Clinical Trial Requirements of Application and Approval f... static version printer friendly pdf version
Material and Clinical Trial Requirements of Application and Approval f... static version printer friendly pdf version
Material and Clinical Trial Requirements of Application and Approval f... static version printer friendly pdf version
Maven Semantic Healthcare Database static version printer friendly pdf version
Maximizing Investment of Returns: Analysis of Ethical Sales Growth and... static version printer friendly
Maximizing Prescribing Opportunities: Capitalizing on Primary and Seco... static version printer friendly
Maximizing Product Returns Through Reformulation: Old Molecules, New O... static version printer friendly
Measuring Ebusiness In The Pharmaceutical Sector: A Strategic Assessme... static version printer friendly
Medetomidine (Vet) - Pipeline Selector static version printer friendly pdf version
Medical Affairs Resources, Structures and Trends static version printer friendly pdf version
Medical Biosensor Applications and Market to 2008 – Diabetes Managemen... static version printer friendly pdf version
Medical Device Company Performance Tables static version printer friendly pdf version
Medical Equipment and Products in Vietnam: A Strategic Reference, 2007... static version printer friendly pdf version
Medical industry, shouldering heavy responsibilities static version printer friendly pdf version
Medical Pharmacology at a Glance, 6th Edition static version printer friendly pdf version
Medical Science Liaisons: Gaining Access and Forging Relationships wit... static version printer friendly pdf version
Medicare Part D - Its impact on US drug pricing issues and role as a d... static version printer friendly
Medicare Part D: Strategies of the Leading Health Plans static version printer friendly pdf version
Medications to Treat High Blood Cholesterol static version printer friendly
Medicinal and Pharmaceutical Products in Austria: A Strategic Referenc... static version printer friendly pdf version
Medicinal Natural Products: A Biosynthetic Approach, 3rd static version printer friendly pdf version
Medicines from Animal Cell Culture static version printer friendly pdf version
Medicines Management static version printer friendly pdf version
mediKOL Insight - Where next for thrombosis? static version printer friendly pdf version
Meeting GMP and ISO 9001 Expectations for Product Development static version printer friendly
Mega Corporation Pipelines: A Postmerger Analysis static version printer friendly pdf version
Mega-Mergers: Executing Change in the Pharma Industry static version printer friendly pdf version
Melanoma Therapeutics: Which Strategy Will Take Us There? static version printer friendly
Meloxicam (Vet) - Pipeline Developer static version printer friendly pdf version
Meloxicam (Vet) - Pipeline Selector static version printer friendly pdf version
Meloxicam - Pipeline Developer static version printer friendly pdf version
Meloxicam - Pipeline Selector static version printer friendly pdf version
Memantine - Pipeline Developer static version printer friendly pdf version
Memantine - Pipeline Selector static version printer friendly pdf version
MemberHealth, Inc. Business Intelligence Report 2007 static version printer friendly pdf version
Memory Impairment Therapy Area Pipeline Report static version printer friendly pdf version
Meningitis - Pipeline Analysis and Market Forecasts to 2016 static version printer friendly pdf version
Menopausal Symptoms Therapy Area Pipeline Report static version printer friendly | |